Chapter 43: Anticoagulants, Antiplatelets & Thrombolytics

Welcome to Last Minute Lecture.

This free chapter overview is designed to help students review and understand key concepts.

These summaries supplement not replaced the original textbook and may not be redistributed or resold.

For complete coverage, always consult the official text.

Hello and welcome back to the Deep Dive.

We are trying something a little different today.

We are.

We know a huge chunk of our listeners are nursing students and well, we know exactly where you are right now.

Oh, I remember it.

The panic is very specific.

It is.

You're probably staring at a textbook the size of a, I don't know, a doorstop and you're realizing you have a massive pharmacology exam in 48 hours.

Or your first day of clinicals is tomorrow and you're just terrified of, you know, doing something wrong.

Absolutely.

So we're calling this little series the Last Minute Lecture.

We're trying to take the heavy lifting out of that late night study session.

We're not just skimming.

Today, we are going deep.

We are tearing apart Chapter 43 of the 12th edition of pharmacology, a patient -centered nursing process approach, the big one,

anticoagulants, antiplatelets, and thrombolytics.

This is, I would argue, one of the most high stakes chapters in the entire curriculum.

It really is.

How so?

Well, look, if you mess up a blood pressure med,

the patient might get dizzy, right?

You can fix that.

If you mess up these drugs, the patient can bleed out or, you know, throw a massive clot to their lung.

The margin for error here is, it's razor thin.

So the mission for us today is clarity.

We have to decode what the book calls the big three.

Right.

We have anticoagulants, antiplatelets, and thrombolytics.

Before we get lost in the weeds of half -lives and receptors, can you just give us the 30 ,000 -foot view?

How do we keep these straight?

The easiest way, I think, to frame it is by their function and their location.

So first up, you have the anticoagulants.

Okay.

I call these the preventors.

Their job is to work primarily in the venous system, the veins, and their whole purpose is to stop new clots from forming.

Or stop existing ones from getting bigger.

Exactly.

Or from getting bigger.

They prevent.

So anticoagulants are the defense.

Got it.

And we have the antiplatelets.

Right.

Sometimes called antithrombotics.

These are what I call the slippery agents.

Ha!

I like that.

Their job is to stop platelets from sticking together, from clumping up.

And while anticoagulants sort of own the veins,

antiplatelets mostly own the arteries.

Okay.

That's a key distinction.

And the third group, the one with the scariest name.

The thrombolytics.

These are the clot busters.

And this distinction right here is probably the most important thing you're going to hear today.

Okay.

I'm listening.

Anticoagulants and antiplatelets.

They cannot destroy a clot that is already there.

I have to say that again.

They cannot get rid of an existing clot.

They just prevent it from growing.

They just hold the line.

Thrombolytics are the only drugs that can actually go in, attack, and dissolve a clot that's already formed.

That is a massive distinction.

So if I have a clot that's already blocking blood flow to my brain, giving me heparin isn't going to make that clot just vanish.

No, not at all.

Yeah.

It might stop it from getting worse.

Sure.

But it will not clear the pipe.

Only a thrombolytic can do that.

Okay.

So we have the landscape.

We have the preventers, the slippery agents, and the clot busters.

But to understand the drugs, we have to respect the enemy.

We have to talk about the clot itself.

Exactly.

The pathophysiology of a thrombus.

What is actually happening biologically when a clot starts to form?

Well, thrombosis is just the fancy word for a blood clot forming inside a vessel where it shouldn't be.

But, and this is key, not all clots are built the same.

So you have to treat them differently.

You have to.

An arterial clot is a different beast from a venous clot because they're formed by totally different mechanics.

Okay.

Let's break that down.

Let's start with the arteries.

High pressure, fast flow.

What kicks off a clot there?

In arteries, it's usually about turbulence and damage.

You get a rupture in the vessel wall or maybe some atherosclerotic plaque bursts open.

The blood flow is super fast.

So the clotting mechanism has to be really aggressive to get a foothold.

And these are often called white clots.

Why white?

Because they are made up almost entirely of platelets.

The whole process is kicked off by platelet aggregation.

The platelets just rush to the scene of the injury.

They stick to the wall and then fibrin comes in later to sort of trap some red blood cells.

But the primary driver, the architect of an arterial clot,

is the platelet.

Which makes perfect sense then why antiplatelet drugs like aspirin, for example, are the go -to for arterial issues.

Like heart attacks and strokes.

Exactly.

You're targeting the architect.

Precisely.

Now contrast that with the veins.

The venous system is low pressure.

The flow is slow.

It's lazy.

Clots here typically form because of stasis.

Blood just sitting around.

Yeah.

Blood just pooling.

Think about a long plane ride or a patient who's bedbound after a big surgery.

The blood isn't moving so it starts to clump up on its own.

Right.

And these are what we call red clots.

They form pretty rapidly and they're made of a mix of platelets and fibrin but they trap a ton of red blood cells which gives them that red color.

And since the structure relies so heavily on fibrin and the coagulation factors.

That's where the anticoagulants come in?

That's where the anticoagulants like warfarin or heparin do their work.

Okay.

But the nightmare scenario with these venous clots, it isn't just that they block a vein in the leg.

It's that they can move.

The embolus.

That is the monster under the bed for every nurse.

A piece of that thrombus in the leg breaks off.

It travels up through the heart and it slams into the pulmonary artery.

A pulmonary embolism.

A P .E.

A P .E.

And it cuts off gas exchange.

The patient is literally suffocating while they're breathing because the blood can't get to the lungs to pick up oxygen.

So when we give these drugs, we aren't just treating a sore leg.

No.

You're preventing a fatal lung event.

You are absolutely saving their life.

Let's zoom in a little bit more on the platelets themselves.

In a healthy person, platelets are just floating around, right?

Like little bumper cars bouncing off each other.

They don't naturally stick.

Correct.

The lining of your blood vessels, the endothelium, is normally super smooth and non -reactive.

But if that lining breaks,

it exposes the collagen underneath, and that acts

like a magnet.

So the platelets stick to the exposed part.

They adhere to the break, and once they stick, they undergo this shape change.

They get all spiky and active even.

They start screaming for help.

That's a great way to put it.

They start synthesizing a substance called thromboxane A2.

Now, this is a crucial molecule to remember for your exam.

Thromboxane A2.

It acts like a megaphone.

It tells all the other platelets floating by, hey, everybody pile on right here.

It is a potent, potent recruiter.

And once they all pile on, they need some kind of glue to hold them together.

And that glue comes from special receptors on the platelet surface,

specifically glycoprotein Ibea.

GP Ibea?

These receptors activate, and they bind to a molecule called fibrinogen, which then physically links the platelets together, forming the plug.

I just want to flag that for everyone listening.

Thromboxane A2 and glycoprotein Ibea.

Those aren't just trivia words you have to memorize.

No, not at all.

Those are the direct targets for the drugs we are about to discuss.

Exactly.

If you understand that thromboxane A2 causes clumping, you understand how aspirin works.

If you understand the glycoprotein receptors, you understand how the heavy duty hospital drugs work.

All right, let's do it.

Let's dive into that first big category, the anticoagulants, the preventers.

Okay.

We established these are mostly for venous issues, DVT and PE.

But the book also says we use them for some arterial conditions.

We do.

We absolutely do.

We use them for patients with artificial heart valves, for example, because the metal or plastic in the valve is a foreign surface that just triggers clotting like crazy.

And for certain kinds of stroke?

Yes.

For strokes that are caused by atrial fibrillation, where clots form in the heart and then travel to the brain.

But the golden rule remains.

Anticoagulants inhibit clot formation.

They are prophylactic.

Okay, let's start with the oldest player in the game, heparin.

Heparin is fascinating.

It was discovered way back in 1938 in the liver,

hence the name hepar, which is Greek for liver.

It's a natural substance.

And it is strictly a needle drug.

There are no heparin pills.

Never.

Heparin is a very large molecule.

It has a strong negative charge and it's completely destroyed by stomach acid and an enzyme called heparinase.

It just can't cross the gut wall.

So it has to be given parenterally.

Right.

Either a subcutaneous injection for prevention or a continuous 5E infusion for acute treatment.

So walk us through the mechanism of action.

How does heparin actually stop the blood from clotting?

It's interesting.

It doesn't actually do it alone.

Heparin needs a partner.

It binds to a protein that's already in your blood called antithrombin the third.

Okay.

When heparin and antithrombin the third hook up, they become this super powered clot inactivating team.

They specifically target and shut down two key players in the clotting cascade, thrombin and factors A.

And without thrombin?

Well, without thrombin, fibrinogen can't be converted into fibrin.

And fibrin is the mesh.

Fibrin is the mesh.

It's the net that holds the entire clot together.

So if you stop the net from forming, you stop the clot.

Because it blocks the cascade at such a central point, it must work fast, right?

Oh, incredibly fast.

5E heparin works within minutes.

That's why we use it for emergencies.

A massive DVT, a PE that's in progress.

Or during open heart surgery, when you need to prevent clotting in the bypass machine.

But with great power comes great risk.

If we turn off the clotting system that completely, the patient could.

Well, they could.

Average is the number one adverse effect.

It's the one we're always watching for.

But there's another really weird one called HIT.

Heparin and boost thrombocytopenia.

This one always confuses students.

They're very confusing.

Because thrombocytopenia means low platelets.

So you would think the patient is bleeding.

You would think so.

Yeah.

But HIT is this paradoxical immune reaction.

The body creates antibodies against the heparin platelet complex.

And this actually activates the platelets and causes them to clump up aggressively everywhere in the body.

So the platelet count drops because they're all being used up.

They're all being used up in thousands of tiny microclots all over the body.

So you get this nightmare scenario of widespread clotting and a high risk of bleeding because you've run out of platelets.

It's a true medical emergency.

So if we see HIT, we stop the heparin immediately?

Instantly.

And you document it.

That patient can never ever get heparin again for the rest of their life.

Okay.

Because heparin is so volatile, we have to monitor it constantly.

This is where the lab tests come in.

Which alphabet soup are we looking at for heparin?

For standard, unfractionated heparin, we look at the APTT, the activated partial thromboplastin time.

And what is a normal APTT for a person who's not on heparin?

Usually it's around 30 to 40 seconds.

That's how long it takes your blood to clot in a test tube.

But if I'm on a heparin drip, we want my blood to take longer to clot.

Exactly.

We want you to be therapeutic.

The goal is usually to have an APTT that is 1 .5 to 2 .5 times the control value.

So we're that's the sweet spot around 60 to 80 seconds.

And if the lab calls and the APTT is say 45?

That's subtherapeutic.

The drug isn't working effectively.

The clot could be growing.

We need to increase the drip rate.

What if it's 110?

That's super therapeutic.

You're way too thin.

You're at a high risk for spontaneous bleeding.

We need to turn the drip down or even stop it for a little while.

Okay.

Let's say we messed up.

The APTT comes back at 150 seconds.

The patient is starting to ooze blood from their IV site.

Do we have an eject button, an antidote?

We do.

The antidote for heparin is protamine sulfate.

And how does that work?

It's actually really cool chemistry.

Remember I said heparin has a strong negative charge?

Right.

Protamine sulfate is a protein that has a strong positive charge.

It binds directly to the heparin molecule like a magnet and neutralizes it instantly.

The dosing is pretty simple too.

One milligram of protamine neutralizes about a hundred units of heparin.

Okay.

So that's standard heparin.

It's high maintenance, lots of labs, it's hospital only.

But now we have the upgraded version, low molecular weight heparin or LMWH.

Yeah.

Drugs like inoxaparin or daltaparin.

What's the difference?

Think of standard heparin as this long messy tangled chain of molecules of all different sizes.

LMWH is what happens when you take that chain and you chop it up into uniform smaller pieces.

And why is that better?

It makes the drug so much more predictable.

Because the molecules are smaller and they're all the same size, the body absorbs and processes them very consistently.

We know exactly what the response is going to be from patient to patient.

Which means no more constant blood draws.

Exactly.

No APTT monitoring is required.

And that's a huge deal because it allows us to send patients home on it.

Right.

If you've ever had a relative get a knee replacement or a hip surgery.

They probably went home with a box of pre -filled syringes of inoxaparin.

They just injected into their belly fat for a few weeks to prevent a DVT.

Oh, that's a massive quality of life difference.

But are there specific rules for administering LMWH that we need to know?

A few big ones.

Never inject it intramuscularly.

It will cause a massive hematoma.

It's always subcutaneous, usually in the abdomen and the love handles area.

And you have to watch out for interactions.

For sure.

Patients should not be taking aspirin

unless a physician has specifically ordered it because the combined effect can dramatically increase bleeding risk.

I'm seeing a patient safety alert here in the text about the names.

Lookalike.

Soundalike.

Oh, this is a classic trap for nursing boards and for real life.

Inoxaparin sounds a lot like anoxicin.

And anoxicin is?

An antibiotic.

Love inox, the brand name for inoxaparin sounds like Lotrinex, which is a drug for irritable bowel syndrome.

You absolutely do not want to mix those up.

So check the spelling, check the label, check it again.

Always.

Okay, let's move on from the heparin family to the pills.

The oral anticoagulants.

For decades, there is really only one king of this hill.

Warfarin.

Warfarin, also known by its brand name, Coumadin,

originally developed as a rat poison, believe it or not.

Because it makes the rats bleed out internally.

Essentially, yes.

Warfarin works completely differently than heparin.

It works in the liver and it inhibits the synthesis of vitamin K.

And why does vitamin K matter for clotting?

The liver needs vitamin K to build four specific clotting factors.

You have to know these.

Factor two, which is prothrombin, factor seven, factor nine X, and factor X.

Two, seven, nine, and ten.

Two, seven, nine, ten.

Warfarin blocks the liver from using vitamin K, so those factors.

It's like a car assembly line that's run out of a critical part.

Right.

The liver just stops producing functional clotting factors.

But this creates a pretty significant timing issue.

A massive timing issue.

This is so important.

Heparin works on the factors that are floating in the blood right now.

It's immediate.

It's immediate.

Warfarin stops the production of new factors.

But the factors that are already floating around your blood still work just fine.

You have to wait for those old circulating factors to die off before warfarin actually takes effect.

And how long does that take?

It can take anywhere from two to five days to reach a therapeutic level.

This brings us to the bridge therapy concept.

This is absolutely vital for clinicals and exams.

Yes.

Let's walk through a scenario.

A patient comes into the ER with a big DDT in their leg.

We start them on an IV heparin drip immediately to stop the clot from getting bigger.

Okay.

We also give them their first warfarin pill on day one.

But we do not stop the heparin drip yet.

We run them both together for several days.

That sounds dangerous, giving two blood thinners at the same time.

It sounds counterintuitive, but it's absolutely necessary.

The heparin is protecting the patient for those first few days while the warfarin is still warming up and getting to a therapeutic level.

And then once the warfarin labs show that it's working.

We can safely stop the heparin drip and send the patient home on just the warfarin pills.

Speaking of warfarin labs.

Yeah.

We don't check APT for warfarin.

No.

For warfarin, we check the PT, prothrombin time, and more importantly, the INR, international normalized ratio.

Okay.

Why the INR?

Why not just use the PT?

Because PT is, frankly, unreliable.

Depending on the specific chemical region that a lab uses, a normal PT could be 12 seconds in one hospital and 15 seconds in another.

It's not standardized.

The INR is a mathematical calculation that standardizes the result.

It means a nurse in New York and a nurse in Tokyo are looking at the exact same number and can make the same clinical judgment.

So what are the magic numbers for the INR?

For a normal person walking down the street, their INR is about 1 .0.

If you are on warfarin for something like DVT or AFib, we want you to be between 2 .0 and 3 .0.

And what if you have a mechanical heart valve?

For mechanical heart valve, we run you a little thinner.

The target INR is a bit higher, usually 2 .5, 3 .5.

What happens if the lab calls and the INR comes back at 5 .0 or 7 .0?

That is panic territory.

That is a critical value.

The blood is way too thin.

The risk of a spontaneous brain bleed or a major GI bleed is massive.

And since warfarin works by blocking vitamin K?

The antidote is vitamin K.

The drug name is fitonadione.

But of course, there's a catch with the antidote too.

Always a catch.

Vitamin K is not instant.

If you give a patient oral vitamin K, it still takes the liver 24 to 48 hours to use it to create new clotting factors.

So if the patient is actively bleeding like,

vomiting blood vitamin K is just too slow.

Way too slow.

For an active life -threatening bleed, we give fresh rosin plasma or FFP.

And FFP is?

It's basically a bag of someone else's clotting factors.

You're not waiting for the body to make them.

You are infusing them directly.

It works immediately.

Let's talk about the diet.

This is the part that I think annoys patients the most.

It's the green leafy vegetable talk.

It's a tough one.

Spinach, kale, broccoli, they're all loaded with vitamin K.

They are.

So if a patient on warfarin suddenly eats a huge spinach salad, they're essentially taking a dose of the antidote to their medication.

They're making the warfarin stop working.

So do we just tell them to never eat a salad again?

No.

That's poor advice.

And it's not sustainable.

We tell them to be consistent.

If you normally eat a cup of spinach every Tuesday,

then please keep eating a cup of spinach every Tuesday.

We can adjust the warfarin dose to account for your stable diet.

The problem is when the intake changes.

Right.

Don't suddenly go on a two -week kale smoothie detox diet without telling us.

Because your INR will crash and you'll be at risk for a clot.

And on the flip side, if you normally eat a lot of greens and then you stop, your INR will spike and you'll be at risk for a bleed.

Warfarin sounds like a headache to manage.

It is.

It is highly protein -bound, which means it interacts with almost every other drug on the planet.

It has a very long half -life, so it builds up in the system.

It requires monthly, sometimes weekly, blood tests.

Which is exactly why the new drugs are starting to take over.

Yes.

The oral factor, the Xi inhibitors, drugs like rivaroxaban, which is a Rolto, and epixaban, which is a Lequis.

And these are the new standard for a lot of patients.

For many, yes.

They are pills, just like warfarin.

But they do not require routine INR monitoring.

They don't have the major dietary restrictions and they start working much, much faster.

They sound perfect.

What's the downside?

Cost is a big one.

They're still very expensive compared to generic warfarin.

And until recently, they didn't have reliable, widely available antidotes.

We do have some now, like Andex and Adalpha.

But they're complex and not as simple as just giving a shot of vitamin K.

There's also a warning here about body weight.

Yes.

That's important.

The book notes that you should not give them to patients weighing less than 50 kilograms as the bleeding risk goes up significantly.

Before we leave anticoagulants, I want to bring this back to the nursing process.

We've covered the chemistry, but what does the nurse actually see at the bedside?

Assessment is everything.

You are a detective looking for signs of bleeding that aren't always obvious.

Sure, a nosebleed epistaxis is obvious.

But you need to look at the gums when they brush their teeth.

Are they bleeding?

Instead of looking at the skin?

At the skin, yes.

Look for petechiae.

Those are the tiny pinpoint red dots that indicate capillaries are breaking.

Look for ecchymosis bruising that seems excessive for the cause or just shows up spontaneously.

And then there's the afka.

Molina.

Dark, tarry, foul -smelling stools.

That's a classic sign of an upper GI bleed.

And hematuria blood in the urine.

What about patient teaching?

We're sending someone home on a drug that prevents their blood from clotting.

How do they stay safe in the real world?

A few non -negotiables.

Soft bristle toothbrush only.

Electric razors only.

No straight blades.

If they cut themselves shaving, it might not stop bleeding for a very long time.

They need a medical -erp bracelet.

Absolutely.

If they get into a car crash and are unconscious, the first responders need to know they are anticoagulated immediately.

It changes everything about their treatment.

And we have to talk about the G herbs.

Ah, the infamous Gs.

Garlic, ginger, ginkgo, ginseng, green tea.

It sounds like a delicious healthy stir -fry.

It does, but it's a disaster with these drugs.

It is.

All of those can increase bleeding risk or interfere with the INR.

And patients don't think to mention them because they think, oh, it's natural, it's safe.

You have to specifically ask and correct that thinking.

Natural can still cause a brain bleed if you mix it with warfarin.

Okay, let's shift gears.

We're leaving the veins and moving into the high -pressure arteries.

Let's talk about the antiplatelets.

The slippery agents.

The most famous drug in the world is in this category.

Aspirin.

Aspirin is just an incredible drug.

It works by inhibiting an enzyme called cyclooxygenase, or COX.

Without the COX enzyme, the platelet cannot make thromboxane A2.

And thromboxane A2 was the recruiter with the megaphone.

Right, so aspirin takes away the megaphone, the platelets never get the signal to clump together.

And I read that the effect is permanent for the life of that platelet.

Yes, that's a key point.

Aspirin binds irreversibly.

A platelet doesn't have a nucleus, so it can't make new enzymes.

Platelets live for about seven to ten days.

So if you take an aspirin today, the platelets that were exposed to it are effectively disabled for the next week.

Which is why we tell patients to stop taking aspirin seven days before planned surgery.

Exactly.

We need a fresh batch of functional platelets to grow so that they can form a clot after the surgeon makes an incision.

We usually see very low doses, right, like 81 milligrams?

The baby aspirin, yes.

We use 81 milligram for long -term prevention.

If someone is having an active heart attack, the protocol is often to give them a 325 milligram tablet and tell them to chew it.

To get it into the system faster.

To get it absorbed through the mucous membranes in the mouth for more rapid effect.

Then we have the common partner to aspirin, clopidogrel.

The brand name is Plevix.

Clopidogrel is an ADP receptor blocker.

It works on a completely different receptor on the platelet surface to prevent activation.

And we often see them prescribed together.

That's called dual antiplatelet therapy, or DAPT.

It's all about synergy.

Aspirin hits one activation pathway, clopidogrel hits another.

It's like locking the front door and the back door to prevent the clot from forming.

And we use this heavily after someone gets a stent placed in their heart.

Very heavily.

It's crucial to prevent the stent from clotting off.

Are there super antiplatelets the next level up?

There are.

These are the glycoprotein IPA inhibitors.

Drugs like exiximab, heptafibatide.

These are IV -only, hospital -only drugs.

And these are the ones that block the glue receptor directly?

Right.

They block the final common pathway of platelet aggregation.

These are the strongest antiplatelets we have.

We use them during an acute coronary syndrome or during an angioplasty, when the cardiologist is physically inside the artery clearing a blockage.

They basically make the platelets completely nonfunctional.

For a short period of time, yes.

The bleeding risk with these is very, very high.

Okay, so we've prevented the clot with anticoagulants and antiplatelets.

But what if we're too late?

The patient comes in.

They're having a massive stroke.

Half their body is paralyzed.

They can't speak.

There is a clot in their brain right now.

Now we enter the realm of the thrombolytics, the clot busters.

And how do they work?

What's the mechanism?

They activate the body's own clot dissolving system, the fibrinolytic system.

They take an inactive substance called plasminogen and convert it into its active form, plasmin.

And what does plasmin do?

Plasmin is an enzyme that acts like a pair of biological scissors.

It goes to the clot and it physically cuts apart the fibrin mesh.

It digests the clot from the inside out.

It literally disintegrates it.

It dissolves it completely.

The main drug we use here is alteplas, which is also called TPA, for tissue plasminogen activator.

This sounds like an absolute miracle drug.

Why don't we just give it to everyone who has a clot?

Because it is essentially Draino for the entire vascular system.

It's incredibly powerful and nonspecific.

It dissolves the bad clot in the brain, yes.

But it also dissolves every good necessary clot in your body.

So if you had a tiny ulcer in your stomach that was scabbed over.

That scab is gone and now you're having a massive GI bleed.

If you had surgery last week, that incision is going to open up and bleed.

The risk of intracranial hemorrhage bleeding into the brain is significant.

So we have to be incredibly selective about who gets this.

Unbelievably selective.

We have a strict checklist and a golden window of time.

For an ischemic stroke, you generally have three hours from the onset of symptoms to give TPA.

Three hours, that's it.

Maybe up to four and a half hours in some very specific cases.

But the rule is three.

If you wait five or six hours, the risk of causing a massive brain bleed outweighs any potential benefit.

The brain tissue is likely already dead by then anyway.

The saying is time is tissue.

Time is brain, exactly.

For a heart attack, an MI, the window is a little wider.

You can see benefits up to 12 hours out.

But again, sooner is always, always better.

So what are the absolute no -Gios who can never, ever get this drug?

If you have active internal bleeding, absolutely not.

If you've had a stroke or significant head trauma in the last three months, no.

If your blood pressure is severely uncontrolled, like 185 over 110, you can't have it.

Because the pressure will just blow out a vessel in the brain?

It will cause a hemorrhagic conversion of the stroke.

You'll bleed directly into your brain.

So once we start the infusion, what is the nurse doing for the next hour?

You are glued to that patient.

You are not leaving that bedside.

You're checking vital signs every 15 minutes.

You are doing neuro checks constantly.

If their headache gets worse, if they become confused, that could be a brain bleed.

You are checking all their IV sites for oozing.

And no needles.

Once that TPA drip starts, you do not poke that patient with anything sharp.

No new IVs, no arterial lines, no intramuscular injections.

You have to get all of your lines and tubes in before you start the drug.

If you poke them, they will form a hematoma and they won't stop bleeding.

Does this group have an antidote?

If the TPA causes a massive bleed, can we reverse it?

Yes, there is one.

It's called aminocaproic acid.

It works by inhibiting the plasminogen activation.

It essentially stops the clot digestion process.

Okay, let's try to bring this all home with the case study from the textbook.

We have a 57 -year -old male diagnosed with thrombophlebitis.

Which is just inflammation of a vein with a clot, usually in the leg.

So he's admitted, and he starts on an IV heparin drip, a 5 ,000 -unit bolus, and then a continuous infusion.

Then, five days later, the provider adds warfarin.

The question is, why didn't they stop the heparin on day five?

It's the bridge.

We just talked about this.

It's that critical overlap period.

Because the warfarin takes days to work.

Exactly.

Warfarin takes two to five days to reach a therapeutic INR.

If you were to stop the heparin on the same day you start the warfarin, that patient would have virtually zero anti -coagulation protection for almost a week.

The clot would almost certainly grow.

You have to overlap them until that INR gets up into the therapeutic range between 2 .0 and 3 .0.

Okay, that makes sense.

Then later in the case study, he's at home on warfarin, and he comes back to the ER vomiting blood, human emesis.

He's toxic.

His warfarin level is way too high.

His INR is probably through the roof.

So as the nurse, what's our priority?

What do we do?

First, ADCs and vital signs.

He's likely hypotensive and tachycardic from the blood loss, so you need to stabilize him, maybe with fluids.

Then you immediately draw labs, especially in INR.

And then we give it the antidote.

We give the antidote.

Administer vitamin K to start the reversal process.

And if he's unstable and actively bleeding, you give fresh frozen plasma to replace those missing clotting factors right away.

It really does illustrate the balance, doesn't it?

We're trying to keep the blood liquid enough to flow everywhere it needs to, but solid enough to stay inside the vessels.

It is the ultimate tightrope walk in pharmacology.

And the nurse is the one holding the safety net, constantly monitoring and adjusting.

So to recap the last minute lecture,

big takeaways for everyone cramming for their exam.

Okay, let's do it.

Number one, anticoagulants like heparin and warfarin are primarily for the veins.

They prevent new clots.

You watch the APTT for heparin and you watch the INR for warfarin.

Number two.

Number two, antiplatelets like aspirin and clopidogrel are primarily for the arteries.

They make platelets slippery to prevent heart attacks and strokes.

And number three.

Number three, thrombolytics like TVA are the nuclear option.

They are the only thing that can dissolve an existing clot, but they carry a massive risk of bleeding.

And you have to watch the clock.

Time is everything.

And watch out for the garlic supplements.

Always, always watch the garlic.

To all the nursing students who are listening to this at two in the morning,

take a deep breath.

You understand the mechanism.

You understand the safety checks.

You've got this.

Good luck on the exam.

You're going to go crush it.

This has been the last minute lecture on the deep dive.

Thanks for listening.